Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

被引：0
|
作者：
Shichong Lin
Lehe Yang
Yulei Yao
Lingyuan Xu
Youqun Xiang
Haiyang Zhao
Liangxing Wang
Zhigui Zuo
Xiaoying Huang
Chengguang Zhao
机构：
[1] Wenzhou Medical University,School of Pharmaceutical Sciences
[2] Wenzhou Medical University,The First Affiliated Hospital
[3] Wenzhou University,The Institute of Life Sciences
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
Flubendazole; Colorectal cancer; STAT3; Autophagy; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
    Lin, Shichong
    Yang, Lehe
    Yao, Yulei
    Xu, Lingyuan
    Xiang, Youqun
    Zhao, Haiyang
    Wang, Liangxing
    Zuo, Zhigui
    Huang, Xiaoying
    Zhao, Chengguang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [2] Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
    Xie, Xiaona
    Cai, Xueding
    Tang, Yemeng
    Jiang, Chunhui
    Zhou, Feng
    Yang, Lehe
    Liu, Zhiguo
    Wang, Liangxing
    Zhao, Haiyang
    Zhao, Chengguang
    Huang, Xiaoying
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [3] Neobavaisoflavone Demonstrates Valid Anti-tumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3
    Cai, Xueding
    Zhou, Feng
    Xie, Xiaona
    Zheng, Dandan
    Yao, Yulei
    Zhao, Chengguang
    Huang, Xiaoying
    Hu, Ke
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25 (01) : 29 - 37
  • [4] Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
    T Zhang
    J Li
    F Yin
    B Lin
    Z Wang
    J Xu
    H Wang
    D Zuo
    G Wang
    Y Hua
    Z Cai
    Oncogene, 2017, 36 : 6627 - 6639
  • [5] Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
    Zhang, T.
    Li, J.
    Yin, F.
    Lin, B.
    Wang, Z.
    Xu, J.
    Wang, H.
    Zuo, D.
    Wang, G.
    Hua, Y.
    Cai, Z.
    ONCOGENE, 2017, 36 (47) : 6627 - 6639
  • [6] Cytoplasmic STAT3 Represses Autophagy by Inhibiting PKR Activity
    Shen, Shensi
    Niso-Santano, Mireia
    Adjemian, Sandy
    Takehara, Tetsuo
    Malik, Shoaib Ahmad
    Minoux, Herve
    Souquere, Sylvie
    Marino, Guillermo
    Lachkar, Sylvie
    Senovilla, Laura
    Galluzzi, Lorenzo
    Kepp, Oliver
    Pierron, Gerard
    Maiuri, Maria Chiara
    Hikita, Hayato
    Kroemer, Romano
    Kroemer, Guido
    MOLECULAR CELL, 2012, 48 (05) : 667 - 680
  • [7] Correction: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
    T. Zhang
    J. Li
    F. Yin
    B . Lin
    Z. Wang
    J. Xu
    H. Wang
    D. Zuo
    G. Wang
    Y. Hua
    Z. Cai
    Oncogene, 2019, 38 : 4655 - 4656
  • [8] A Specific STAT3-Binding Peptide Exerts Antiproliferative Effects and Antitumor Activity by Inhibiting STAT3 Phosphorylation and Signaling
    Kim, Daejin
    Lee, In-Hyun
    Kim, Sunghyun
    Choi, Minsuk
    Kim, Hyungjun
    Ahn, Sukyung
    Saw, Phei Er
    Jeon, Hyungsu
    Lee, Yumi
    Jon, Sangyong
    CANCER RESEARCH, 2014, 74 (08) : 2144 - 2151
  • [9] The role of STAT3 in autophagy
    You, Liangkun
    Wang, Zhanggui
    Li, Hongsen
    Shou, Jiawei
    Jing, Zhao
    Xie, Jiansheng
    Sui, Xinbing
    Pan, Hongming
    Han, Weidong
    AUTOPHAGY, 2015, 11 (05) : 729 - 739
  • [10] STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer
    Njatcha, Christian
    Farooqui, Mariya
    Kornberg, Adam
    Johnson, Daniel E.
    Grandis, Jennifer R.
    Siegfried, Jill M.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (09) : 1917 - 1926
12345